Romá-Mateo Carlos, Aguado Carmen, García-Giménez José Luis, Ibáñez-Cabellos José Santiago, Seco-Cervera Marta, Pallardó Federico V, Knecht Erwin, Sanz Pascual
Instituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Científicas (IBV-CSIC), C/Jaime Roig, 11, 46010, Valencia, Spain.
Mol Neurobiol. 2015;51(3):932-46. doi: 10.1007/s12035-014-8747-0. Epub 2014 May 17.
Lafora disease (LD, OMIM 254780, ORPHA501) is a fatal neurodegenerative disorder characterized by the presence of glycogen-like intracellular inclusions called Lafora bodies and caused, in the vast majority of cases, by mutations in either EPM2A or EPM2B genes, encoding respectively laforin and malin. In the last years, several reports have revealed molecular details of these two proteins and have identified several processes affected in LD, but the pathophysiology of the disease still remains largely unknown. Since autophagy impairment has been reported as a characteristic treat in both Lafora disease cell and animal models, and as there is a link between autophagy and mitochondrial performance, we sought to determine if mitochondrial function could be altered in those models. Using fibroblasts from LD patients, deficient in laforin or malin, we found mitochondrial alterations, oxidative stress and a deficiency in antioxidant enzymes involved in the detoxification of reactive oxygen species (ROS). Similar results were obtained in brain tissue samples from transgenic mice deficient in either the EPM2A or EPM2B genes. Furthermore, in a proteomic analysis of brain tissue obtained from Epm2b-/- mice, we observed an increase in a modified form of peroxiredoxin-6, an antioxidant enzyme involved in other neurological pathologies, thus corroborating an alteration of the redox condition. These data support that oxidative stress produced by an increase in ROS production and an impairment of the antioxidant enzyme response to this stress play an important role in development of LD.
拉福拉病(LD,OMIM 254780,孤儿病编号501)是一种致命的神经退行性疾病,其特征是存在称为拉福拉小体的糖原样细胞内包涵体,在绝大多数情况下,该病由分别编码拉福林和malin的EPM2A或EPM2B基因突变引起。在过去几年中,一些报告揭示了这两种蛋白质的分子细节,并确定了LD中受影响的几个过程,但该疾病的病理生理学在很大程度上仍然未知。由于自噬功能障碍已被报道为拉福拉病细胞和动物模型的一个特征性表现,并且由于自噬与线粒体功能之间存在联系,我们试图确定在这些模型中线粒体功能是否会发生改变。使用来自缺乏拉福林或malin的LD患者的成纤维细胞,我们发现了线粒体改变、氧化应激以及参与活性氧(ROS)解毒的抗氧化酶缺乏。在缺乏EPM2A或EPM2B基因的转基因小鼠的脑组织样本中也获得了类似的结果。此外,在对从Epm2b-/-小鼠获得的脑组织进行的蛋白质组学分析中,我们观察到过氧化物酶体增殖物激活受体6(一种参与其他神经病理学的抗氧化酶)的一种修饰形式增加,从而证实了氧化还原状态的改变。这些数据支持由ROS产生增加和抗氧化酶对这种应激的反应受损所产生的氧化应激在LD的发展中起重要作用。